Lee Jihyun, Lee Byung Joo, Lee Yeong Mi, Park Hansoo, Kim Jeong Hun, Kim Won Jong
Center for Self-Assembly and Complexity, Institute for Basic Science (IBS) , Pohang 37673, Republic of Korea.
Department of Chemistry, Pohang University of Science and Technology (POSTECH) , Pohang 37673, Republic of Korea.
Mol Pharm. 2017 May 1;14(5):1460-1468. doi: 10.1021/acs.molpharmaceut.6b00949. Epub 2017 Feb 22.
Here, nanoconstructs consisting of a DNA-amplified aptamer with a biocompatible polymer backbone for capturing target biomolecules are presented. First, the polymer-DNA nanoconstructs were prepared by hybridization of two complementary single-stranded DNAs that were each conjugated to a dextran polymer backbone. The designed polymer-DNA amplified aptamer nanoconstructs (PA-aNCs) were then prepared by utilizing polymer-DNA nanoconstructs conjugated with an aptamer (PA-NCs) using a rolling circle amplification reaction to amplify the aptamer. These PA-aNCs were successfully applied to alleviate tumor growth and vascular endothelial growth factor (VEGF)-induced retinal vascular hyperpermeability in vivo through the highly effective capture of human VEGF as a target molecule. These PA-aNCs could be used as therapeutic agent for anti-VEGF therapy by efficiently capturing human VEGF.
本文介绍了一种纳米构建体,其由具有生物相容性聚合物主链的DNA扩增适配体组成,用于捕获靶标生物分子。首先,通过将两条分别与葡聚糖聚合物主链偶联的互补单链DNA杂交来制备聚合物-DNA纳米构建体。然后,利用与适配体偶联的聚合物-DNA纳米构建体(PA-NCs),通过滚环扩增反应来扩增适配体,从而制备出设计好的聚合物-DNA扩增适配体纳米构建体(PA-aNCs)。这些PA-aNCs通过高效捕获人血管内皮生长因子(VEGF)作为靶标分子,成功地在体内减轻了肿瘤生长和VEGF诱导的视网膜血管高通透性。这些PA-aNCs可以通过有效捕获人VEGF用作抗VEGF治疗的治疗剂。